January 2024

The Cambridge Open Zettascale Lab has unveiled the UK’s fastest AI supercomputer, called Dawn Phase 1. The supercomputer, powered by the latest Intel GPUs and CPUs, combines artificial intelligence and high-performance computing

New research from King’s College London has shown that artificial intelligence (AI) can predict the survival of brain cancer patients who have received radiotherapy treatment. The use of AI in predicting patient

TLDR: As AI Costs Soar, Some Startups Consider Selling Several artificial intelligence startups are considering selling or merging with larger companies due to the high costs associated with developing AI software. Many

TLDR: Kriya FinTech, a player in the B2B fintech sector, has secured a £50m ($66m) debt facility from long-standing partner Viola Credit. The funding will be used to expand Kriya’s payment processing

TLDR: Nubis Communications and Alphawave Semi have demonstrated optical PCIe 6.0 technology at DesignCon. The companies showcased a PCIe 6.0 optical link operating at 64 GT/s per lane, driven by an Alphawave

TLDR: Saurabh Saxena, Group CIO of PDS Ltd, discusses how the company is integrating fashion with cutting-edge technology PDS Ltd is focused on staying ahead of evolving customer behavior and preferences In

New Technology in the Search for Alien Intelligence TLDR: In a recent study, scientists are using new technology and techniques to search for signs of intelligent alien life beyond our own galaxy.

The article explores the ethical considerations, technological trends, and challenges associated with integrating emerging technologies in the healthcare industry. It highlights the importance of balancing technological efficiency with maintaining the human touch

PB Fintech, the parent company of Policy Bazaar and Paisa Bazaar, has seen its stock price cross its IPO price after two years, gaining 12.5% on strong Q3 results. The company reported

TLDR: A new technology has been developed to increase the visibility of cancer cells to the immune system, potentially leading to a new way to treat cancer. The technology involves augmenting the